Dr. Michael Amylon, MD
Palo Alto, CA
43 Years of Experience
Who is Dr. Amylon, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Dr. Michael Amylon, MD is a Pediatric Hematologist-Oncologist, who primarily practices in Palo Alto, CA. He has been practicing for over 43 years and is board certified by the American Board of Pediatrics and American Board of Dermatology. Dr. Amylon graduated from Stanford University School of Medicine and completed his residency at Stanford Univ Hosp, Pediatric Hematology-Oncology; Stanford Univ Hosp, Pediatrics. Dr. Amylon is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Amylon’s office at (650) 497-8953.
What are Areas of Expertise for Dr. Amylon?
Dr. Michael Amylon, MD is a highly-rated, board-certified Pediatric Hematologist-Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Amylon empowers patients to confidently navigate their health journey, specializing in Leukemia & Lymphoma, Stem Cell Transplant, or comprehensive wellness support. Serving the Palo Alto/CA community, Dr. Amylon is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Amylon go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine CA
Residency: Stanford Univ Hosp, Pediatric Hematology-Oncology; Stanford Univ Hosp, Pediatrics | Stanford University Medical Center
Medical School: Stanford Univ Sch Of Med- Stanford Ca | Stanford University School of Medicine
Is Dr. Amylon board certified in Pediatric Hematologist-Oncologist?
Yes, Dr. Michael Amylon, MD is board certified by the American Board of Pediatrics , American Board of Dermatology since 1982, American Board of Pediatrics since 1980
What languages does Dr. Amylon speak?
Dr. Amylon and their clinical team can communicate with patients in the following languages:
English
Spanish
Which conditions does Dr. Amylon treat as a Pediatric Hematologist-Oncologist?
As a Pediatric Hematologist-Oncologist, conditions treated by a Dr. Michael Amylon may include:
Please contact Dr. Amylon's office for more information or to schedule a consultation.
Which procedures does Dr. Amylon perform as a Pediatric Hematologist-Oncologist?
As a Pediatric Hematologist-Oncologist, procedures performed by a Dr. Michael Amylon may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Amylon's office.
Does Dr. Amylon accept my insurance?
Please contact Dr. Amylon's office to confirm accepted insurance plans.
Where is Dr. Amylon's office located?
Recognitions
Publications
SAFETY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN LESS THAN THREE YEARS OF AGE
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2008
Projective drawings as measures of psychosocial functioning
JOURL OF PEDIATRIC ONCOLOGY NURSING, 2008
Hematopoietic stem cell transplantation after first marrow relapse of non-T
JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006
Siblings of pediatric cancer patients: The quantitative and qualitative ture of quality of life
JOURL OF PSYCHOSOCIAL ONCOLOGY, 2005
High-dose therapy and autologous hematopoietic stem
JOURL OF CLINICAL ONCOLOGY, 2004
Camp Okizu: Prelimiry investigation of a psychological intervention for siblings of pediatric
CHILDRENS HEALTH CARE, 2004
Allogeneic hematopoietic cell transplantation for patients with high
EXPERIMENTAL HEMATOLOGY, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003
High-dose therapy and autologous hematopoietic cell transplantation in children with primary
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic
LEUKEMIA, 1999
Intensive high-dose asparagise consolidation improves survival for pediatric patients with T cell
LEUKEMIA, 1999
Cyclosporine, methotrexate
Biology of blood and marrow transplantation, 1999
Fractioted total-body irradiation, etoposide
Biology of blood and marrow transplantation, 1997
Allogeneic bone marrow transplant in pediatric patients with high
JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997
Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia
PEDIATRIC BLOOD & CANCER, 2006
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.
Pharmacological reviews, 2004
Development and testing of the School Competency Assessment Scale.
Jourl of pediatric oncology nursing, 2003
Genetic polymorphisms in CYP3A5
PHARMACOGENETICS, 2002
Bone marrow stroma-supported culture of T
LEUKEMIA, 2002
Relationship of p15
BRITISH JOURL OF HAEMATOLOGY, 2001
New recurring cytogenetic abnormalities
BLOOD, 2000
Slow disappearance of peripheral blood blasts is an adverse prognostic factor
LEUKEMIA, 2000
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia
LEUKEMIA, 2000
Cost alysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia
MEDICAL AND PEDIATRIC ONCOLOGY, 2000
Glutathione S-transferase genotypes in children who develop treatment
LEUKEMIA, 2000
Significance of commonly used prognostic factors differs
LEUKEMIA, 1999
Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants
BONE MARROW TRANSPLANTATION, 1999
Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T
CANCER RESEARCH, 1999
Somatization, anxiety and depression as measures of health-related quality of life of children
Challinor, J. M., Miaskowski, C. A., Franck, L. S., Slaughter, R. E., , 1999
Randomized trial of r
JOURL OF CLINICAL ONCOLOGY, 1998
Bone marrow transplant in thalassemia - A role for radiation?
COOLEYS ANEMIA, 1998
Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B
BLOOD, 1997
Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with P16
LEUKEMIA RESEARCH, 1997
Influence of age on the outcome of 500 autologous bone marrow transplant procedures
KUSNIERZGLAZ, C. R., Schlegel, P. G., Wong, R. M., Schriber, J. R., Ch, 1997
Bone marrow transplant in thalassemia at Stanford University: A role for radiation?
Lee, Y. S., Kristovich, K. M., Ducore, J. M., Vichinsky, E., Crouse, V, 1996
Influence of preparatory regimen
Biology of blood and marrow transplantation, 1996
Pleuropulmory blastoma: A marker for familial disease
JOURL OF PEDIATRICS, 1996
Identifying early predictors of mortality in pediatric patients with acute leukemia and pneumonia
CHEST, 1996
BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE
JOURL OF CLINICAL ONCOLOGY, 1995
DOES ACTIVATION OF THE TAL1 GENE OCCUR IN A MAJORITY OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC
BLOOD, 1995
FRACTIOTED TOTAL-BODY IRRADIATION AND HIGH
BLOOD, 1994
BONE-MARROW TRANSPLANTATION FOR THALASSEMIA - THE USA EXPERIENCE
Walters, M. C., Thomas, E. D., 1994
ROLE OF ETOPOSIDE (VP
Blume, K. G., Long, G. D., Negrin, R. S., Chao, N. J., KUSNIERZGLAZ, C, 1994
FRACTIOTED TOTAL-BODY IRRADIATION AND HIGH
BLOOD, 1993
CYCLOSPORINE, METHOTREXATE
NEW ENGLAND JOURL OF MEDICINE, 1993
HRX INVOLVEMENT IN DENOVO AND SECONDARY LEUKEMIAS WITH DIVERSE CHROMOSOME 11Q23 ABNORMALITIES
BLOOD, 1993
MULTIFOCAL LEUKOENCEPHALITIS CAUSED BY VARICELLA-ZOSTER VIRUS IN A CHILD WITH LEUKEMIA
PEDIATRIC INFECTIOUS DISEASE JOURL, 1993
CLINICAL-FEATURES AND OUTCOME OF T
BLOOD, 1993
BUSULFAN ETOPOSIDE - INITIAL EXPERIENCE WITH A NEW PREPARATORY REGIMEN FOR AUTOLOGOUS BONE
BLOOD, 1993
LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VE-CAVA SYNDROME - A CASE-REPORT
MEDICAL AND PEDIATRIC ONCOLOGY, 1993
T(2-14)(P13-Q32) - A RECURRING ABNORMALITY IN LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP
CANCER GENETICS AND CYTOGENETICS, 1992
Allogeneic bone marrow transplantation for high
Blood, 1991
ALLOGENEIC BONE-MARROW TRANSPLANTATION AS THERAPY FOR PRIMARY INDUCTION FAILURE FOR PATIENTS WITH
JOURL OF CLINICAL ONCOLOGY, 1991
PHILADELPHIA-CHROMOSOME AND MONOSOMY
BLOOD, 1991
LACK OF TRANSMISSION OF THE LIVE ATTENUATED VARICELLA VACCINE VIRUS TO IMMUNOCOMPROMISED CHILDREN
PEDIATRICS, 1991
Dermatoglyphics and acute lymphocytic leukemia in children.
Jourl of pediatric oncology nursing, 1991
TREATMENT OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990
THE T(1-14)(P34-Q11) IS NONRANDOM AND RESTRICTED TO T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A
BLOOD, 1990
REPOPULATION OF MARROW AFTER TRANSPLANTATION - MR IMAGING WITH PATHOLOGICAL CORRELATION
RADIOLOGY, 1990
Bone marrow transplantation for hematologic maligncies: the Stanford experience.
Clinical transplants, 1990
REDUCED NEUTROPHIL COUNTS IN CHILDREN WITH TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD
JOURL OF PEDIATRICS, 1989
AFTER TREATMENT ENDS - PSYCHOSOCIAL SEQUELAE IN PEDIATRIC CANCER SURVIVORS
AMERICAN JOURL OF ORTHOPSYCHIATRY, 1988
IDIOTYPE AS A TUMOR-SPECIFIC MARKER IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
BLOOD, 1988
CLINICAL AND BIOLOGIC CHARACTERIZATION OF T-CELL NEOPLASIAS WITH REARRANGEMENTS OF CHROMOSOME
BLOOD, 1988
ESTABLISHMENT AND CHARACTERIZATION OF A COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA CELL
CANCER RESEARCH, 1987
PREDNISONE STIMULATION OF ERYTHROPOIESIS IN LEUKEMIC CHILDREN DURING REMISSION
AMERICAN JOURL OF HEMATOLOGY, 1986
INTENSIVE RETREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 1ST BONE
NEW ENGLAND JOURL OF MEDICINE, 1986
CHROMOSOME-9 ABNORMALITIES IN CHILDHOOD T-CELL LEUKEMIA
NEW ENGLAND JOURL OF MEDICINE, 1986
VARICELLA ZOSTER ANTIBODY
AMERICAN JOURL OF MEDICINE, 1984
IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
JOURL OF PEDIATRICS, 1984
COMPARISON OF VARICELLA ZOSTER ANTIBODY
JOURL OF PEDIATRICS, 1984
CRANIAL NERVE INVOLVEMENT IN CHILDREN WITH LEUKEMIA AND LYMPHOMA
JOURL OF CLINICAL ONCOLOGY, 1983
A SINGLE MONOCLOL-ANTIBODY IDENTIFIES T-CELL LINEAGE OF CHILDHOOD LYMPHOID MALIGNCIES
BLOOD, 1983
What is Dr. Amylon's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Amylon's National Provider Identifier (NPI) number is 1396931291.
What common questions do patients ask about Dr. Amylon?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Amylon
What is Dr. Michael Amylon's specialty?
Dr. Amylon is a Pediatric Hematologist-Oncologist near Palo Alto, CA. A pediatrician trained in the integration of pediatrics, hematology, and oncology, specializing in the recognition and management of blood disorders and cancer in children. This expert provides comprehensive care for conditions such as anemia, bleeding disorders, and various pediatric cancers. Contact Dr. Amylon to book an appointment today.
Is this Dr. Michael Amylon affiliated with a ranked Castle Connolly Top Hospital?
No, Amylon is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Pediatric Hematologist-Oncologist?
Explore Pediatric Hematologist-Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Michael Amylon accepting new patients in Palo Alto, CA?
Yes, Dr. Michael Amylon is accepting new patients at this time.
Does Dr. Michael Amylon offer online booking?
Please contact Dr. Amylon's office at (650) 497-8953 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Michael Amylon?
Please contact Dr. Amylon's office at (650) 497-8953 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Michael Amylon have?
Dr. Michael Amylon is certified by the American Board of Pediatrics and American Board of Dermatology.
Other Pediatric Hematologist-Oncologist Near Palo Alto, CA
Pediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patients